| 0 |
THIRD DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0238 |
| 1 |
PRODUCT DIFFICULT TO REMOVE |
1 |
0.0167 |
| 2 |
ANTICOAGULATION DRUG LEVEL ABNORMAL |
1 |
0.0067 |
| 3 |
ABSCESS SOFT TISSUE |
1 |
0.0065 |
| 4 |
CERVIX HAEMORRHAGE UTERINE |
1 |
0.0052 |
| 5 |
PRODUCT CONTAMINATION CHEMICAL |
1 |
0.0046 |
| 6 |
HORMONE RECEPTOR POSITIVE BREAST CANCER |
1 |
0.0037 |
| 7 |
ULTRASOUND SCAN ABNORMAL |
1 |
0.0026 |
| 8 |
SOFT TISSUE SWELLING |
1 |
0.0018 |
| 9 |
METAL POISONING |
1 |
0.0017 |
| 10 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 11 |
APPLICATION SITE DERMATITIS |
1 |
0.0011 |
| 12 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 13 |
DERMAL CYST |
2 |
0.0008 |
| 14 |
AXILLARY PAIN |
1 |
0.0007 |
| 15 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 16 |
BREAST CYST |
1 |
0.0006 |
| 17 |
SKIN INDURATION |
1 |
0.0005 |
| 18 |
PURULENT DISCHARGE |
2 |
0.0005 |
| 19 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 20 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 21 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 22 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 23 |
MACULE |
1 |
0.0004 |
| 24 |
SKIN WARM |
2 |
0.0003 |
| 25 |
SKIN EROSION |
1 |
0.0003 |
| 26 |
APPLICATION SITE RASH |
4 |
0.0003 |
| 27 |
CERVIX CARCINOMA |
1 |
0.0003 |
| 28 |
WOUND SECRETION |
1 |
0.0003 |
| 29 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 30 |
FURUNCLE |
2 |
0.0003 |
| 31 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 32 |
SKIN SWELLING |
2 |
0.0002 |
| 33 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 34 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 35 |
APPLICATION SITE PAIN |
4 |
0.0002 |
| 36 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 37 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 38 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 39 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 40 |
SKIN MASS |
1 |
0.0001 |
| 41 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 42 |
ABNORMAL FAECES |
1 |
0.0001 |
| 43 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 44 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 45 |
BREAST CANCER STAGE I |
1 |
0.0001 |
| 46 |
DEFORMITY |
1 |
0.0001 |
| 47 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 48 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 49 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 50 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 51 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 52 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 53 |
GASTROENTERITIS |
1 |
0.0001 |
| 54 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 55 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 56 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 57 |
LYMPHOMA |
1 |
0.0001 |
| 58 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 59 |
ABSCESS |
1 |
0.0001 |
| 60 |
SCAR |
1 |
0.0001 |
| 61 |
RASH MACULAR |
2 |
0.0001 |
| 62 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 63 |
DERMATITIS |
1 |
0.0000 |
| 64 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 65 |
SKIN IRRITATION |
2 |
0.0000 |
| 66 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 67 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 68 |
RASH GENERALISED |
1 |
0.0000 |
| 69 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 70 |
PAIN OF SKIN |
1 |
0.0000 |
| 71 |
SKIN LESION |
1 |
0.0000 |
| 72 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 73 |
RHINORRHOEA |
2 |
0.0000 |
| 74 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 75 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 76 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 77 |
DYSARTHRIA |
1 |
0.0000 |
| 78 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 79 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 80 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 81 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 82 |
CELLULITIS |
1 |
0.0000 |
| 83 |
ERYTHEMA |
4 |
0.0000 |
| 84 |
NERVOUSNESS |
1 |
0.0000 |
| 85 |
RASH |
8 |
0.0000 |
| 86 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 87 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 88 |
BLISTER |
1 |
0.0000 |
| 89 |
EYE PAIN |
1 |
0.0000 |
| 90 |
BURNING SENSATION |
1 |
0.0000 |
| 91 |
DYSGEUSIA |
1 |
0.0000 |
| 92 |
ACNE |
1 |
0.0000 |
| 93 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 94 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 95 |
TACHYCARDIA |
1 |
0.0000 |
| 96 |
SWELLING |
1 |
0.0000 |
| 97 |
PRURITUS |
4 |
0.0000 |
| 98 |
ASTHMA |
1 |
0.0000 |
| 99 |
SEIZURE |
1 |
0.0000 |
| 100 |
CHILLS |
1 |
0.0000 |
| 101 |
HYPERHIDROSIS |
1 |
0.0000 |
| 102 |
RENAL FAILURE |
1 |
0.0000 |
| 103 |
DEHYDRATION |
1 |
0.0000 |
| 104 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 105 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 106 |
DYSPNOEA |
4 |
0.0000 |
| 107 |
INFECTION |
1 |
0.0000 |
| 108 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 109 |
HEADACHE |
4 |
0.0000 |
| 110 |
URTICARIA |
1 |
0.0000 |
| 111 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 112 |
CHEST PAIN |
1 |
0.0000 |
| 113 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 114 |
ASTHENIA |
2 |
0.0000 |
| 115 |
ALOPECIA |
1 |
0.0000 |
| 116 |
SOMNOLENCE |
1 |
0.0000 |
| 117 |
FEELING ABNORMAL |
1 |
0.0000 |
| 118 |
WEIGHT DECREASED |
1 |
0.0000 |
| 119 |
COUGH |
1 |
0.0000 |
| 120 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 121 |
PAIN |
2 |
0.0000 |
| 122 |
PNEUMONIA |
1 |
0.0000 |
| 123 |
PYREXIA |
1 |
0.0000 |
| 124 |
FATIGUE |
1 |
0.0000 |
| 125 |
NAUSEA |
1 |
0.0000 |
| 126 |
OFF LABEL USE |
1 |
0.0000 |
| 127 |
DRUG INEFFECTIVE |
1 |
0.0000 |